Hvas AM - Search Results

1

The activated partial thromboplastin time may not reveal even severe fibrinogen deficiency.

Abildgaard A, Hvas AM. Abildgaard A, et al. Among authors: hvas am. Clin Chem Lab Med. 2021 Jan 28;59(7):e297-e300. doi: 10.1515/cclm-2020-1626. Print 2021 Jun 25. Clin Chem Lab Med. 2021. PMID: 33544482 No abstract available.

2

Dosage of Anticoagulants in Obesity: Recommendations Based on a Systematic Review.

Abildgaard A, Madsen SA, Hvas AM. Abildgaard A, et al. Among authors: hvas am. Semin Thromb Hemost. 2020 Nov;46(8):932-969. doi: 10.1055/s-0040-1718405. Epub 2020 Dec 23. Semin Thromb Hemost. 2020. PMID: 33368113 Free article.

3

Arterial and venous blood sampling is equally applicable for coagulation and fibrinolysis analyses.

Christensen SH, Nissen PH, Hjørnet NE, Greisen JR, Hvas AM. Christensen SH, et al. Among authors: hvas am. Clin Chem Lab Med. 2022 Aug 10;60(11):1847-1854. doi: 10.1515/cclm-2022-0567. Print 2022 Oct 26. Clin Chem Lab Med. 2022. PMID: 35946852

4

Quantification of holo-transcobalamin, a marker of vitamin B12 deficiency.

Nexo E, Christensen AL, Hvas AM, Petersen TE, Fedosov SN. Nexo E, et al. Among authors: hvas am. Clin Chem. 2002 Mar;48(3):561-2. Clin Chem. 2002. PMID: 11861448 No abstract available.

5

Holo-transcobalamin is an early marker of changes in cobalamin homeostasis. A randomized placebo-controlled study.

Nexo E, Hvas AM, Bleie Ø, Refsum H, Fedosov SN, Vollset SE, Schneede J, Nordrehaug JE, Ueland PM, Nygard OK. Nexo E, et al. Among authors: hvas am. Clin Chem. 2002 Oct;48(10):1768-71. Clin Chem. 2002. PMID: 12324494 Clinical Trial.

6

Holotranscobalamin as a predictor of vitamin B12 status.

Hvas AM, Nexo E. Hvas AM, et al. Clin Chem Lab Med. 2003 Nov;41(11):1489-92. doi: 10.1515/CCLM.2003.228. Clin Chem Lab Med. 2003. PMID: 14656030

7

Holo-transcobalamin concentration and transcobalamin saturation reflect recent vitamin B12 absorption better than does serum vitamin B12.

Bor MV, Nexø E, Hvas AM. Bor MV, et al. Among authors: hvas am. Clin Chem. 2004 Jun;50(6):1043-9. doi: 10.1373/clinchem.2003.027458. Epub 2004 Mar 25. Clin Chem. 2004. PMID: 15044317

8

Autoantibodies against intrinsic factor (IF) measured with an ELISA using recombinant human IF as both catching and detecting reagent.

Nexo E, Nooroya B, Hvas AM, Christensen AL, Waters H. Nexo E, et al. Among authors: hvas am. Clin Chem Lab Med. 2005;43(4):351-6. doi: 10.1515/CCLM.2005.064. Clin Chem Lab Med. 2005. PMID: 15899648

9

Evaluation of the technical performance of novel holotranscobalamin (holoTC) assays in a multicenter European demonstration project.

Morkbak AL, Heimdal RM, Emmens K, Molloy A, Hvas AM, Schneede J, Clarke R, Scott JM, Ueland PM, Nexo E. Morkbak AL, et al. Among authors: hvas am. Clin Chem Lab Med. 2005;43(10):1058-64. doi: 10.1515/CCLM.2005.185. Clin Chem Lab Med. 2005. PMID: 16197298

10

Circadian variation of holo-transcobalamin (holo-TC) and related markers.

Hvas AM, Gravholt CH, Nexo E. Hvas AM, et al. Clin Chem Lab Med. 2005;43(7):760-4. doi: 10.1515/CCLM.2005.130. Clin Chem Lab Med. 2005. PMID: 16207139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters